AstraZeneca Partners With AmoyDx On Companion Diagnostics For Lynparza

 
• By Joseph Haas

Deal Snapshot: Teaming again with the Shanghai biotech, AstraZeneca will seek assays that can be incorporated into companion diagnostics for Lynparza in prostate and breast cancer.

Diagnostic test
AstraZeneca is partnering to develop additional companion diagnostics for Lynparza • Source: Alamy

More from Deals

More from Business